Pcn133 Economic Evaluation of Epidermal Growth Factor Receptor - Tyrosine Kinase Inhibitor (egfr-tki) Drugs in Non-small Cell Lung Cancer (nsclc) Treatment: a Systematic Review of Recent Studies
Year: 2020
Type: conference-abstract
Source: Value in Health
Authors: M. Karim, A.K. Nabil, N. Khodakarami, H.C. Kum, M.J. Foster, R.L. Ohsfeldt
Institution: Texas A&M University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W3026216247
